Financials
Financial year 2025
PHARMACIE DE LA BRISEE from Mons, company number BE0456841195, closed financial year 2025 with a result of € 38,183 after tax. For that financial year PHARMACIE DE LA BRISEE recorded a gross margin of € 200,839 and equity of € 782,498. Compared with financial year 2024, the result moved from € 71,121 to € 38,183. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.
€ 782,498
▼ 7% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,183
▼ 46% vs 2024
Profit after tax over the fiscal year.
€ 224,085
▲ 152% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 95,331 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2025
1.2
▼ 0.1 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 102,248
▲ 3% vs 2024
€ 85,200 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 17,188
▼ 31% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 41,496
▼ 26% vs 2024
€ 14,977 is repaid this year. At this pace the long-term loan is gone in ≈ 3 years.
€ 61,792
▼ 34% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 17,931
▼ 17% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 255,909 | € 202,612 | € 240,772 | € 200,839 | ▼ 17% |
| Profit after taxes | € 95,331 | € 47,615 | € 71,121 | € 38,183 | ▼ 46% |
| Equity | € 723,409 | € 770,225 | € 839,646 | € 782,498 | ▼ 7% |
| Total debts | € 164,169 | € 150,304 | € 174,627 | € 217,227 | ▲ 24% |
| Cash | € 253,074 | € 185,982 | € 88,978 | € 224,085 | ▲ 152% |
| Land & buildings | € 427,629 | € 398,066 | € 363,875 | € 329,684 | ▼ 9% |
| Retained profit | € 644,817 | € 691,633 | € 761,054 | € 703,906 | ▼ 8% |
| Dividend | € 800 | € 800 | € 1,700 | € 95,331 | ▲ € 93,631 |
| Bank debt | € 85,673 | € 71,072 | € 56,347 | € 41,496 | ▼ 26% |
| Balance sheet total | € 887,578 | € 920,529 | € 1,014,273 | € 999,725 | ▼ 1% |
| Employees (FTE) | 1.1 | 1.3 | 1.3 | 1.2 | ▼ 0.1 |
Key figures of PHARMACIE DE LA BRISEE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE DE LA BRISEE?
What happened at PHARMACIE DE LA BRISEE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 38,183 (▼ 46% vs 2024). Source: NBB ↗
- New establishment in Mons. KBO
- Start of the company according to the CBE. KBO
In short
From € 95,331 profit in 2022 to € 38,183 profit in 2025.
Paid € 104,603 in corporate taxes since 2022.
Best year ever: 2022, with € 95,331 profit.
On average € 167,400 of value added per employee in 2025.
A new publication or filing at PHARMACIE DE LA BRISEE? We notify you, reason included.
Follow PHARMACIE DE LA BRISEEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of Pharmacie Gosselin-Obourg comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
PHARMACIE DE LA BRISEEBehind PHARMACIE DE LA BRISEE are JULIE SAUDOYEZ CAROLINE, FRANCOIS GOSSELIN and Gosselin-Obourg pharmacie. The shares are held by Pharmacie Gosselin-Obourg (49.9%).
Directors
According to the 2025 annual accounts
JULIE SAUDOYEZ CAROLINE
Administrator-manager
Director · represented by François Gosselin
Shareholders
Participations
No participations in other companies reported.
Establishments
Establishment units
Physical locations of this company
Rue de la Brisée (O.) 163/A
7034 Mons
Rue de la Brisée (O.) 143
7034 Mons
Active since 8 February 1996
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0456.841.195
- VAT number
- BE 0456.841.195
- Registered office
- Rue de la Brisée (O.) 163/A, 7034 Mons
- Names & denominations
- PHARMACIE DE LA BRISEE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 27 December 1995
- Peppol
- Active · Active since 5 Dec 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers
Detailhandel in cosmetica en toiletartikelen